🇺🇸 Nicorette Inhaler in United States

31 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Intentional Drug Misuse — 7 reports (22.58%)
  2. Nicotine Dependence — 7 reports (22.58%)
  3. Product Quality Issue — 3 reports (9.68%)
  4. Abnormal Behaviour — 2 reports (6.45%)
  5. Drug Dependence — 2 reports (6.45%)
  6. Headache — 2 reports (6.45%)
  7. Injury — 2 reports (6.45%)
  8. Overdose — 2 reports (6.45%)
  9. Physical Assault — 2 reports (6.45%)
  10. Swollen Tongue — 2 reports (6.45%)

Source database →

Other Smoking Cessation / Addiction Medicine approved in United States

Frequently asked questions

Is Nicorette Inhaler approved in United States?

Nicorette Inhaler does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Nicorette Inhaler in United States?

Ottawa Heart Institute Research Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.